LAB vs ROP · rev $174.4M vs P/E 41, rev $1.88B
Standard Biotools Inc (LAB) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
LAB currently screens at market cap $317.1M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the LAB and ROP stock pages for the full models.
Not investment advice.